Cardiomyocyte apoptosis in vasorenal hypertension as a consequence of catabolism error

Abstract

Aim. To investigate the effects of phosphocreatine and ethylmethylhydroxypyridine succinate on cardiomyocyte apoptosis intensity and degree of ventricular cardiomyocytes hypertrophy in rabbits with vasorenal hypertension (VH) model. Methods. VH was modeled on rabbits by artificial abdominal aortic stenosis by one-third of the diameter just above the renal arteries arising. Rabbits were divided to 4 groups: rabbits with 4-week VH without treatment, rabbits with 4-week VH treated with phosphocreatine, rabbits with 4-week VH treated with ethylmethylhydroxypyridine succinate, and healthy rabbits (control group). Cardiomyocyte apoptosis intensity and degree of ventricular cardiomyocytes hypertrophy was assessed in all of the rabbits by evaluation of nuclear-cytoplasmic ratio. Results. Use of phosphocreatine or ethylmethylhydroxypyridine succinate led to a significant reduction of the apoptotic index in the left ventricular myocardium, whereas the similar effect on the right ventricle was only typical for phosphocreatine. None of these drugs had an effect on myocardial hypertrophy degree, which remained on the same level as in the untreated hypertensive animals. Conclusions. Energy deficiency is one of the factors inducing cardiomyocyte apoptosis, so administration of phosphocreatine or ethylmethylhydroxypyridine succinate might be an important component of heart failure prevention and treatment in hypertension. Myocardial hypertrophy has no effect on the cardiomyocyte apoptosis intensity in case of proper energy supply.

Keywords

apoptosis / cardiomyocytes / hypertrophy / arterial hypertension / phosphocreatine / ethylmethylhydroxypyridine succinate

References

[1] Азова М.М., Благонравов М.Л., Гигани О.Б. и др. Мексидол как регулятор каспазозависимой апоптотической гибели клеток миокарда при артериальной гипертензии различного генеза // Человек и его здоровье. - 2012. - №2. - С. 10-13.

[2] Азова М.М., Благонравов М.Л., Демуров Е.А., Фролов В.А. Энергетический дефицит как возможный фактор индукции каспазозависимого апоптоза клеток миокарда левого желудочка при генетически обусловленной и вторичной артериальной гипертензии // Бюлл. эксп. биол. и мед. - 2012. - Т. 153, №6. - С. 800-802.

[3] Бершова Т.В., Монаенкова С.В., Гасанов А.Г. Патогенетическое значение апоптоза кардиомиоцитов при сердечной недостаточности // Педиатрия. - 2009. - Т. 88, №1. - С. 147-154.

[4] Благонравов М.Л., Азова М.М., Фролов В.А. Активность каспазы 3 и каспазы 8 в миокарде желудочков сердца при экспериментальной дифтерийной интоксикации // Вопр. биол. мед. и фарм. хим. - 2011. - №2. - С. 28-31.

[5] Благонравов М.Л., Азова М.М., Фролов В.А. Биохимическое исследование апоптоза клеток миокарда при острой перегрузке левого желудочка в эксперименте // Вопр. биол. мед. и фарм. хим. - 2010. - №8. - С. 49-53.

[6] Fabris B., Candido R., Bortoletto M. et al. Dose and time-dependent apoptotic effects by angiotensin II infusion on left ventricular cardiomyocytes // J. Hypertens. - 2007. - Vol. 25, N 7. - P. 1481-1490.

[7] Goldblatt H., Kahn J.R. Experimental hypertension: constriction of the aorta at various levels // JAMA. - 1938. - Vol. 9. - P. 685.

[8] Gustafsson A.B., Gottlieb R.A. Heart mitochondria: gates of life and death // Cardivasc. Res. - 2008. - Vol. 77. - Р. 334-343.

[9] Kang P.M., Izumo S. Apoptosis in heart: basic mechanisms and implications in cardiovascular diseases // TRENDS in Molec. Med. - 2003. - Vol. 9, N 4. - P. 177-182.

[10] Kang P.M., Izumo S. Apoptosis and heart failure. A critical review of the literature // Circ. Res. - 2000. - Vol. 86. - P. 1107-1113.

[11] Lemasters J.J., Theruvath T.P., Zhong Z., Nieminen A.-L. Mitochondrial calcium and the permeability transition in cell death // Biochim. Biophys. Acta. - 2009. - Vol. 1787, N 11. - P. 1395-1401.

[12] Ravassa S., Fortuno M.A., Gonzalez A. et al. Mechanisms of increased susceptibility to angiotensin II-induced apoptosis in ventricular cardiomyocytes of spontaneously hypertensive rats // Hypertension. - 2000. - Vol. 36. - P. 1065-1071.

[13] Sugamura K., Keaney Jr.J.F. Reactive oxygen species in cardiovascular disease // Free Radic. Biol. Med. - 2011. - Vol. 51, N 5. - P. 978-992.

RIGHTS & PERMISSIONS

Azova M.M., Blagonravov M.L., Frolov V.A.